InMed Pharmaceuticals Inc. sell Global_Player
Start price
24.10.23
/
50%
€1.40
Target price
24.10.24
-
Performance (%)
-62.14%
End price
28.10.23
€0.53
Summary
This prediction ended on 28.10.23 with a price of €0.53. Global_Player correctly predicted massive losses of -62.14% for InMed Pharmaceuticals Inc.. Global_Player has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| InMed Pharmaceuticals Inc. | - | - | - |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% |
According to Global_Player what are the pros and cons of InMed Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by Global_Player for this prediction
In the thread Inmed Pharmaceuticals Inc. diskutieren
Sell InMed Pharmaceuticals Inc.